Plain-English translation of NCT05388331 on ClinicalTrials.gov β Β· Source last updated Β· Translation generated Β· How we translate trials
Read our Multiple Sclerosis research guide βThis international study is building a large database of people who have white matter abnormalities on brain MRI scans that resemble multiple sclerosis (MS), but who have no symptoms yet. Researchers want to follow these people over time to identify who is most likely to develop MS and what factors predict this progression. By collecting detailed information about imaging, blood tests, and other markers, the study aims to better understand and predict MS development in at-risk individuals.
About half of people with these brain changes develop MS symptoms within 10 years, but doctors cannot yet reliably predict who will and who won't. This study exists to identify early warning signs and risk factors that could help doctors predict MS development and potentially intervene earlier.
You likely qualify ifβ¦
You likely don't qualify ifβ¦
You would join an international registry and be followed over time with regular visits involving MRI scans of your brain and spinal cord, blood tests, and possibly other assessments like eye movement tests and questionnaires. Researchers will also ask about your lifestyle, vitamin D levels, and infection history. The study is still recruiting participants and will continue for years so that doctors can track who develops MS symptoms and identify the factors that predict this progression.
AI-generated summary from trial data Β· Jun 16, 2026 Β· Not medical advice
France
Centre Hospitalier Universitaire de Nice
Enrollment target
~1,000 participants
Started
April 2022
Primary completion
April 2023
This trial's estimated completion date has passed β the record may not be fully up to date.
Last updated on clinicaltrials.gov in May 2022.
Reach out to the team running this trial. Response times vary β some teams are faster than others.
Central contact
Christine LEBNRUN-FRENAY
Centre Hospitalier Universitaire de Nice
Tell us you're interested and we'll help connect you with the research team. We'll walk you through what to expect first β no email needed to get started.